Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration

Adoptive cellular therapy has made a landmark change within the treatment paradigm of several hematologic malignancies, and novel cellular therapy products, such as chimeric antigen receptor T‐cell therapy (CART), have demonstrated impressive efficacy and produced durable responses. However, the CAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatwood, Katie S., Dholaria, Bhagirathbhai R., Lucena, Mariana, Baer, Brittney, Savani, Bipin N., Oluwole, Olalekan O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176074/
https://www.ncbi.nlm.nih.gov/pubmed/35844300
http://dx.doi.org/10.1002/jha2.333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176074/
https://www.ncbi.nlm.nih.gov/pubmed/35844300
http://dx.doi.org/10.1002/jha2.333

Ejemplares similares